Medicare Enrolled

Dr. John Christoforidis, M.D.

Ophthalmology · Columbus, OH
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
456 W 10TH AVE, Columbus, OH 43210
6142930793
In practice since 2006 (20 years)
NPI: 1801833447 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Christoforidis from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Christoforidis? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Christoforidis

Dr. John Christoforidis is an ophthalmology specialist in Columbus, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Christoforidis performed 33,836 Medicare services across 4,257 unique beneficiaries.

Between the years covered by Open Payments, Dr. Christoforidis received a total of $8,685 from 25 pharmaceutical and/or device companies across 147 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Christoforidis is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 2% volume in OH $8,685 industry payments

Medicare Practice Summary

Medicare Utilization ↗
33,836
Medicare services
Top 2% in OH for ophthalmology
4,257
Unique beneficiaries
$81
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,692 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab)
An injection of faricimab-svoa, a medication administered in 0.1 mg doses.
22,420 $29 $60
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
3,076 $30 $100
Aflibercept eye injection (Eylea) 2,210 $683 $1,249
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
1,793 $68 $100
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
1,508 $96 $361
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
879 $85 $150
Extended exam of back of eye with optic nerve drawing
A detailed examination of the posterior section of the eye, including the optic nerve, with documentation through drawing.
683 $11 $50
Injection, ranibizumab, 0.1 mg 492 $177 $500
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
336 $99 $200
Dexamethasone intravitreal implant injection
An injection of a dexamethasone implant placed inside the eye. This procedure delivers medication directly into the vitreous cavity of the eye.
175 $155 $250
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
88 $1 $20
Extended eye exam with retinal drawing
A detailed examination of the back of the eye that includes creating a drawing of the retina.
68 $17 $50
Bevacizumab injection, 10 mg
Administration of a 10 mg dose of bevacizumab medication via injection.
60 $56 $120
Injection into eye membrane
A procedure involving the injection of a drug or substance into the membrane that covers the eyeball.
20 $30 $158
Vitreous removal between lens and retina
This procedure involves the removal of the vitreous fluid located between the lens and the retina of the eye.
17 $675 $2,441
Retinal angiography with dye injection
This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body.
11 $103 $200
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$8,685
Total received (2018-2024)
Avg $1,241/year across 7 years
Top 12% in OH for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
25
Companies
147
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,685 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,575
2023
$2,296
2022
$2,241
2021
$542
2020
$330
2019
$565
2018
$135

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Alimera Sciences, Inc.
$1,343
Astellas Pharma US Inc
$257
Glaukos Corporation
$182
Mallinckrodt Hospital Products Inc.
$178
Genentech USA, Inc.
$176
Regeneron Healthcare Solutions, Inc.
$142
Genentech, Inc.
$101
Alcon Vision LLC
$82
Apellis Pharmaceuticals, Inc.
$79
ABBVIE INC.
$34
Top 3 companies account for 69.2% of 2024 payments
All-time payments by company (2018-2024) ›
Alimera Sciences, Inc.
$4,478
Genentech USA, Inc.
$730
EyePoint Pharmaceuticals US, Inc.
$569
Novartis Pharmaceuticals Corporation
$547
Regeneron Healthcare Solutions, Inc.
$425
Astellas Pharma US Inc
$318
Mallinckrodt Hospital Products Inc.
$253
Apellis Pharmaceuticals, Inc.
$217
Glaukos Corporation
$182
RxSight Inc
$142
Coherus Biosciences Inc.
$142
GLAUKOS CORPORATION
$124
Genentech, Inc.
$101
Biogen, Inc.
$86
Alcon Vision LLC
$82
Mallinckrodt Enterprises LLC
$73
Allergan Inc.
$58
ABBVIE INC.
$34
Mallinckrodt LLC
$28
Spark Therapeutics, Inc.
$18
ThromboGenics, Inc.
$18
Bausch & Lomb Americas Inc.
$17
VYERA PHARMACEUTICALS, LLC
$15
Allergan, Inc.
$13
Bausch & Lomb, a division of Bausch Health US, LLC
$12
Top 3 companies account for 66.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · BEOVU · Cimerli · Constellation · DEXYCU · Daraprim · EYLEA · EYLEA HD · ILUVIEN · ISTENT · Iluvien · Izervay · Jetrea · LUXTURNA · Lucentis · OZURDEX · RETISERT · RXSIGHT CONTACT LENS · Susvimo · Syfovre · VABYSMO · Vabysmo · XIPERE · YUTIQ · iDose
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an ophthalmology specialist in Columbus?
Compare ophthalmologists in the Columbus area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
117
Per 100K population
8.9
County median income
$73,795
Nearest hospital
OHIO STATE UNIVERSITY STATE HEALTH SYSTEM
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Christoforidis is a mixed practice specialist, with above-average Medicare volume (top 2% in OH), with low-engagement industry engagement in the top 12% of OH peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Christoforidis experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Christoforidis performed 22,420 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Christoforidis receive payments from pharmaceutical companies?
Yes. Dr. Christoforidis received a total of $8,685 from 25 companies across 147 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Christoforidis's costs compare to other ophthalmologists in Columbus?
Dr. Christoforidis's average Medicare payment per service is $81. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Christoforidis) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →